Joshua Bleharski
Chief Financial OfficerDr. Joshua Bleharski, Ph.D., M.B.A., is Chief Financial Officer of IDEAYA Biosciences, Inc. from May 2025. Dr. Bleharski joined the IDEAYA Biosciences, Inc. on May 1, 2025. Prior to IDEAYA. Dr. Bleharski served as a Managing Director and Global Co-Head of Biopharma with J.P. Morgan's Healthcare Investment Banking group. Dr. Bleharski is Lead Independent Director of Scribe Therapeutics Inc. from July 23, 2026. Prior to that, Dr. Bleharski served in a variety of roles at J.P Morgan’s Healthcare Investment Banking group from July 2008 to April 2025, most recently as a Managing Director and Global Co-Head of Biopharma. He worked as a Senior Staff Scientist at a private biotechnology company in San Diego and was a post-doctoral fellow at the La Jolla Institute for Allergy and Immunology (LIAI) and the UCLA School of Medicine. Dr. Bleharski has B.S. in Biology from Duke University. Dr. Bleharski has Ph.D. in Immunology and Microbiology from University of California, Los Angeles. Dr. Bleharski has M.B.A. from University of California, Berkeley Haas School of Business.
公司职务
- 公司名称IDEAYA Biosciences, Inc.股票代码IDYA职务Chief Financial Officer共事同僚
- YSYujiro S. HataFounder, President, CEO & Chairman
- ARAndres Ruiz BrisenoChief Accounting Officer
- DBDouglas B. SnyderChief Legal Officer
- MAMichael A. WhitePresident of Research & Development
- JLJeffrey L. SteinIndependent Director
- SWScott William MorrisonIndependent Director
- FPFrank P. McCormickChair of Scientific Advisory Board
- TJTerry J. RosenLead Independent Director
- 公司名称Scribe Therapeutics Inc.股票代码SCTX职务Lead Independent Director共事同僚
- BLBenjamin L. OakesCo-Founder, President, CEO & Chairman
- DLDavid L. ParrotCFO & Treasurer
- SLSvetlana LucasChief Operating Officer
- JAJennifer A. DoudnaCo-Founder & Scientific Advisor
- BTBrett T. StaahlCo-Founder & VP of External Innovation
- JDJames Dean WatsonIndependent Director
- JBJoshua BleharskiLead Independent Director
- BABehzad AghazadehIndependent Director
- CLCarl Lee GordonIndependent Director
